Navigation Links
Study finds more than one-third of human genome regulated by RNA

For many years, DNA and proteins have been viewed as the real movers and shakers in genomic studies, with RNA seen as little more than a messenger that shuttles information between the two. But researchers from Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology have discovered that small RNA molecules called microRNAs regulate thousands of human genes--more than one third of the genome's protein-coding regions. In other words, a class of molecule once relegated to the sidelines may be one of the principal players in regulating cellular mechanisms.

"It's exciting to see how many genes are regulated by microRNAs. We now know that this type of gene control is much more widespread than previously appreciated," says Whitehead Member and MIT professor of biology David Bartel. MicroRNAs interrupt a gene's ability to make protein. These tiny, single-stranded pieces of RNA are newcomers to biological research. It wasn't until 2000 that researchers even knew that microRNAs existed in humans. Now, in the January 14 edition of the journal Cell, Benjamin Lewis, a graduate student working jointly with Whitehead's Bartel and MIT associate professor of biology Christopher Burge, provides the first evidence that microRNAs influence a large percentage of life's functions. The team developed a computational method to define the relationship between microRNAs and their target genes. In December 2003, the same group identified 400 genes in the human genome targeted by microRNAs. (Prior to this study, there were no known microRNA targets in any vertebrate.) In their latest paper, taking advantage of the most recent genome-sequencing data, the team has compared human genome data with that of the dog, chicken, mouse, and rat. For each of the microRNAs and protein-coding genes that are common to these five species, the team looked for correspondence between the microRNAs and the protein-coding genes. They discovered that regulation of a third of th
'"/>

Source:Whitehead Institute for Biomedical Research


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
9. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
10. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
11. Study: Soap And Water Work Best In Ridding Hands Of Disease Viruses

Post Your Comments:
(Date:11/5/2009)... , Kent State University has been awarded a train...nal Science Foundation under its Integrative Gradu...ram. This is the first IGERT grant to be awarded t... American Recovery and Reinvestment Act of 2009, r...ject that focuses on environment aquatic resource ...
(Date:11/4/2009)... , Vancouver, BC - Lowly bacteria, it turns out, ...nufacturing plants around the world clean up toxic...mines, specifically RDX, were invented back in Wor... for decades. These high-energy compounds are oft...powerful version of TNT. , But with increased ...
(Date:11/4/2009)... , REDWOOD CITY, Calif., Oct. 20 /PRNewswire/...identity and authentication solutions, today annou...point-of-sale (POS) software for quick-service res... into their NextGen POS and Classic POS solutions....print biometrics to boost cashier accountability a...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Diane Adams Joins Allscripts as Executive Vice President Human Resources 52078 1Diane Adams Joins Allscripts as Executive Vice President Human Resources 52078 2Diane Adams Joins Allscripts as Executive Vice President Human Resources 52078 3Diane Adams Joins Allscripts as Executive Vice President Human Resources 52078 4Leukemia Lymphoma Society Pleased to Announce Partnership in Southern Ohio with Eisen Marketing Group 52076 1Leukemia Lymphoma Society Pleased to Announce Partnership in Southern Ohio with Eisen Marketing Group 52076 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 1Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 3Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 4
...rrison has been awarded the Society for Pediatric...uished Service Award. , Demmler-Harrison, directo...ospital and professor of Pediatrics at Baylor Coll...Pediatric Academic Societies, Annual Meeting in Ba...merican Pediatric Society, Society for Pediatric R...
...or pigment in skin and hair -- may be placing dark...o nicotine dependence and tobacco-related carcinog...entists., "We have found that the concentration o...arettes smoked daily, levels of nicotine dependenc... said Gary King, professor of biobehavioral health...
... but on the riseand infants are the most common vi...y that aims to raise awareness of this often overl...r in the UGA College of Pharmacy, and recent gradu...ederal mortality data and identified 523 deaths du...to a rate of 0.26 poisonings per million people. T...
Other Biology News:Skin color clue to nicotine dependence 2Study finds homicidal poisoning rising, more likely in infants and elderly 2
(Date:11/6/2009)...if., Nov. 6 Intarcia Therapeutics,...A 650 (DUROS® continuous delivery of exenatid... the Ninth Annual Diabetes Technology Meeting in S....com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, C...TCA 650 Lowers Plasma Glucose, HbA1c and Reduces W...
(Date:11/5/2009)..., Md., Nov. 5 GenVec, In...results for the third quarter ended September 30, ...$0.04 per share) for the three months ended Septem...n ($0.08 per share) in the comparable quarter of 2... GenVec,s net loss was $14.1 million ($0.15 per sh...
(Date:11/5/2009)...ov. 5 Imagenetix, Inc. (...lliam Spencer, President and CEO of Imagenetix, wi...nual LD MICRO Conference on Thursday, December 3rd...s. ,, About LD MICRO ,, LD MICRO is a by-inv...ng undervalued companies in the micro-cap space. S...
(Date:11/5/2009)... Nov. 5 Transgenomic, In...ncial results for the quarter ended September 30, ...d in the tables that follow. ,, Third Quarter ...6,000 or $0.01 per share for the third quarter of ...1 per share for the third quarter of 2008. ,, ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...cessful DSMB Review From Ongoing Phase II BRAINz S...Group,(Debiopharm), a global independent biopharma...s medical conditions and particularly oncology, an...pendent Data Safety Monitoring,Board (DSMB), the C...hase,II BRAINz study with Debio 9902 SR (sustained...
...TVALE, N.J., March 3 Barr Pharmaceuticals,Inc. (N... Court for the,District of New Jersey has ruled in... in the challenge of the patent listed by Bayer Sc...g,s Yasmin(R) (drospirenone and,ethinyl estradiol)...,Sheridan found that the patent at issue was inval...
...THERSBURG, Md., March 3 Iomai Corporation,(Nasdaq...rth quarter and,year-end 2007 financial results be...nd live webcast to discuss corporate and clinical ...astern Time., Conference Call Details, To access...1:30 p.m.,Eastern Time via phone, please dial 866-...
Other Biology Technology:Clinical Update - Debio 9902 SR in Alzheimer's Disease 2Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge 2Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge 3Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge 4Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6 2
Adipocyte Lipolysis Colorimetric Assay Kit from Zen-Bio, Inc.
Coating-3 Reagent, 35mL from Caliper Life Sciences
Calcium Flux Agonist Chip, 4-Sipper (coated) from Caliper Life Sciences
Experion Pro260 Chips, 10 from Bio-Rad
Biology Products: